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In the O1 strain of Klebsiella, the lipopolysaccharide (LPS) O-antigen is composed
of D-galactan I and D-galactan II. Although the composition of the O1 antigen of
Klebsiella was resolved more than two decades, the genetic locus involved in the
biosynthesis of D-galactan II and the role of D-galactan II in bacterial pathogenesis
remain unclear. Here, we report the identification of the D-galactan II-synthesizing genes
by screening a transposon mutant library of an acapsulated Klebsiella pneumoniae O1
strain with bacteriophage. K. pneumoniae strain deleted for wbbY exhibited abrogated
D-galactan II production; altered serum resistance and attenuation of virulence. Serologic
analysis of K. pneumoniae clinical isolates demonstrated that D-galactan II was more
prevalent in community-acquired pyogenic liver abscess (PLA)—causing strains than in
non-tissue-invasive strains. WbbY homologs, WbbZ homologs, and lipopolysaccharide
structures based on D-galactan II also were present in several Gram-negative bacteria.
Immunization of mice with the magA-mutant (K−1 O1) (that is, with a LPS D-galactan
II-producing strain) provided protection against infection with an O1:K2 PLA strain. Our
findings indicate that both WbbY and WbbZ homologs are sufficient for the synthesis of
D-galactan II. D-galactan II represents an immunodominant antigen; is conserved among
multiple species of Gram-negative bacteria and could be a useful vaccine candidate.
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INTRODUCTION
Several Gram-negative bacterial pathogens decorate their surfaces
with exopolysaccharide (EPS), including capsular polysaccha-
ride (CPS) and lipopolysaccharide (LPS). LPS is composed of
lipid A, core oligosaccharide, and O antigenic polysaccharide.
The O antigen contributes to serum resistance of several Gram-
negative bacteria and also is a determinant of bacterial virulence
(Krishnapillai, 1971; Taylor, 1976; Schneider et al., 1982; Tomas
et al., 1986; Hong and Payne, 1997; Hsieh et al., 2012).
K. pneumoniae is an opportunistic pathogen that causes several
kinds of infections, including pneumonia, bacteremia, urinary
tract infection, and community-acquired pyogenic liver abscess
(PLA) (Podschun and Ullmann, 1998; Ko et al., 2002; Ramphal
and Ambrose, 2006; Tsai et al., 2008). There are 9 O antigens
found in Klebsiella species, of which O1 is the most common
serotype among clinical K. pneumoniae isolates (Alberti et al.,
1993; Hansen et al., 1999). Our previous study showed that
Abbreviations: LPS, lipopolysaccharide; D-Gal I, D-galactan I; D-Gal II,
D-galactan II; EPS, exopolysaccharide; CPS, capsular polysaccharide; PLA,
community-acquired pyogenic liver abscess; LMW, low-molecular-weight; HMW,
high-molecular-weight; 5′-RACE, 5′-Rapid Amplification of cDNA Ends; IP,
intraperitoneal; PFU, plaque-forming units; CFU, colony-forming units; CI, com-
petitive index.
amongK. pneumoniae causing PLA, the O1 serotype is highly pre-
dominant, with a prevalence rate of 90% (Hsieh et al., 2012). The
O1 antigen contains two domains: D-Gal I and D-Gal II. The low-
molecular-weight (LMW) D-Gal I polymers, which are directly
linked to the core oligosaccharide, are composed of repeat units
of the structure →3)-β-D-Galf -(1→3)-α-D-Galp-(1→. The wb
(rfb) cluster, which is composed of six genes (wzm,wzt, glf,wbbM,
wbbN, and wbbO), is required for the production of D-Gal I
(Whitfield et al., 1991; Clarke and Whitfield, 1992). The high-
molecular-weight (HMW) D-Gal II polymers, which are linked
to the distal ends of D-Gal I polymers, consist of repeat units
of the structure →3)-α-D-Galp-(1→3)- β-D-Galp-(1→, and are
required for the resistance of K. pneumoniae to complement-
mediated serum killing (McCallum et al., 1989). However, the
location and identity of the genes required for D-Gal II biosyn-
thesis are still unknown.
Bacteriophages target different capsule- or O- types ofK. pneu-
moniae by recognizing surface molecules.Klebsiella bacteriophage
O1-A, which infects the non-capsulated K. pneumoniae KD2
strain, has been used to screen and identify LPS mutants with
spontaneous chromosomal mutations (McCallum et al., 1989).
O1-A phage-resistant KD2 mutants have been classified into 2
basic types: those lacking high-molecular-weight (HMW) LPS
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and those lacking both LMW- and HMW-LPS. However, phage
screening did not identify the genetic determinants of D-Gal II
biosynthesis in the K. pneumoniae O1 strain (McCallum et al.,
1989).
In the present study, we performed a bacteriophage screen
of LPS-deficient mutants of an acapsulated K. pneumoniae O1
strain; these mutants had been derived from the parent strain
by transposon mutagenesis. Using this screen, we identified and
characterized the genetic locus involved in the biosynthesis of D-
Gal II of the O1 antigen; examined the distribution of the D-Gal
II antigen in PLA and non-tissue-invasive K. pneumoniae clinical
isolates; investigated the distribution of the D-Gal II-synthesizing
genes in E. coli O19 and other Gram-negative bacteria; explored
the role of D-Gal II of K. pneumoniae in serum-killing and the
pathogenesis of bacteremia; and investigated whether antiserum
raised against LPS D-Gal II protected against D-Gal II-producing
bacterial infection.
MATERIALS AND METHODS
ETHICS STATEMENT
The study was approved by the Research Ethics Committee
(REC) of the National Taiwan University Hospital (NTUH) (IRB
approval #: 9561701018). All animal procedures were approved
under application number 20140062 of the Institutional Animal
Care and Use Committee (IACUC) of the National Taiwan
University College of Medicine (NTUCM). Procedures were con-
sistent with the recommendations of the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health and
Taiwan’s Animal Protection Act.
BACTERIAL STRAINS AND CULTURE CONDITIONS
The bacterial strains used in this study are listed in Table S1.
The K. pneumoniae NTUH-K2044 was isolated from a patient
with liver abscess-complicated meningitis and endophthalmitis
(Fang et al., 2004). The K-antigen Klebsiella reference strains
were obtained from the Statens Serum Institute (Copenhagen,
Denmark). A total of 74 clinical isolates of K. pneumoniae were
collected from 1997 to 2003 in the National Taiwan University
Hospital, as described previously (Hsieh et al., 2008). K. pneu-
moniae and E. coli strains were cultured in Luria-Bertani (LB)
medium or LB medium supplemented with appropriate antibi-
otics, including 100μg/mL ampicillin, 50μg/mL kanamycin, or
100μg/mL chloramphenicol.
ISOLATION OF K. pneumoniae BACTERIOPHAGE O1-1
The magA deletion mutant was co-incubated with water from
rivers of Taiwan in LB broth overnight. After centrifugation, the
supernatant was filtered using a 0.45-μm filter and spotted onto
LB plates overlaid with themagAmutant to detect phage plaques.
An agar overlay method was used for isolation of a pure phage
preparation and to determine phage titers as described elsewhere
(Pieroni et al., 1994).
CONSTRUCTION OF MUTANT LIBRARY OF THE magAMUTANT
A mutant library of the magA-deletion strain was constructed
using random mutagenesis as previously described (Fang et al.,
2004).
SCREENING FOR PHAGE-RESISTANT MUTANTS FROM THE
magA-DELETION TRANSPOSON MUTANT LIBRARY
Lytic activity of O1-1 bacteriophage against the magA-deletion
transposon mutants was measured with a spot test. A volume of
1μL of 103 plaque forming units (PFU) of the O1-1 bacterio-
phage was used; the sensitivity of the magA-deletion transposon
mutants against the O1-1 was observed by formation of a clear
circular zone.
SEMI-RANDOM PCR AND DNA SEQUENCING
Transposon-insertion sites were determined by semi-random
PCR and DNA sequencing as described elsewhere (Chun et al.,
1997). The primer pairs for semi-random PCR are listed in
Table S1.
DETERMINATION OF THE TRANSCRIPTION INITIATION SITES OFwbbY
ANDwbbZ GENES
5′-Rapid Amplification of cDNA Ends (RACE) -PCR was
performed using the SMARTer RACE cDNA Amplication
Kit (Clontech Laboratories) following the manufacturer’s
instructions.
GENE DELETION AND COMPLEMENTATION
K. pneumoniae mutated in wbbY, wbbZ [polar and non-polar
(NP)],magAwbbY (doublemutant), orwza wzb (doublemutant)
were constructed using the previously described unmarked dele-
tion method (Hsieh et al., 2008), which employs electroporation
and selection with a temperature-sensitive vector (pKO3-Km)
containing flanking regions for each target gene (Simon et al.,
1983). For trans-complementation, wbbY, wbbZ with the inter-
genic region, wbbY with its intact promoter, or the entire wbbY-
wbbZ region from K. pneumoniae NTUH-K2044 and E. coli
F8188-41 were amplified by PCR and cloned into the pACYC184
vector (Fermentas). The recombinant pACYC184-derived plas-
mids were transformed into the wbbY, wbbZ, wbbZ-NP, and
wbbY magA (double-mutant) strains by electroporation. The
primer pairs for the deletion and complementation constructs are
listed in Table S1. All sequence data for the wbbY-wbbZ regions
fromNTUH-K2044 and F8188-41 have been deposited (GenBank
accession numbers KJ451390 and KJ451391).
BACTERIAL GROWTH ASSAYS
An 18-h culture of each strain was used to inoculate each 5-ml
LB broth aliquot at a ratio of 1:100. Each culture was grown at
37◦C and growth was monitored hourly by serial dilution and
plating to LB agar with next-day quantitation of colony-forming
units (CFU).
EXTRACTION AND QUANTIFICATION OF CAPSULAR
POLYSACCHARIDES (CPS)
The amount of K1 CPS from each strain was determined by assay-
ing uronic acid content as described by Domenico (Domenico
et al., 1989).
LPS ANALYSIS
The exopolysaccharide (EPS) extracts (containing both CPS and
LPS) were purified by a modified hot water–phenol extraction
method, as described previously (Chuang et al., 2006; Hsieh
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et al., 2012). Samples were separated by 14% sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) contain-
ing 4M urea (Tsai and Frasch, 1982) and visualized by silver
staining (Tsai and Frasch, 1982). For immunoblots, samples were
separated by SDS-PAGE and blotted to a Hybond-C membrane
(Amersham, Little Chalfont, UK). Anti-D-Gal II antiserum was
obtained from a rabbit immunized with amagA-mutant K. pneu-
moniae as described elsewhere (LTK BioLaboratories, TW); this
serum was diluted 1/50,000 for LPS D-Gal II analysis.
NMR SPECTROSCOPY
Proton spectra were carried out at 500 MHz at 25◦C on solu-
tions formulated in D2O by using a spectral width of 8.5 KHz,
a 32K data block, and a 90◦ pulse in a Bruker AVII-500 LC-
NMR (Billerica, Massachusetts, USA) spectrometer with standard
pulsed sequences and Bruker software.
wbbY ANDwbbZ DETECTION
In order to detect wbbY and wbbZ homologs in various species,
PCR was performed using primer pairs specific for wbbY and
wbbZ. Primers used in this study are listed in Table S1. PCR was
performed as described elsewhere (Chuang et al., 2006).
SERUM KILLING ASSAYS
The survival of exponential-phase bacteria in non-immune
human serum was measured as previously described (Hsieh et al.,
2012). Briefly, a log-phase inoculum of 2.5 × 104 CFU was mixed
at a 1:3 or 3:1 vol/vol ratio with mixed non-immune human
serum donated by 5 healthy volunteers. The final mixture, com-
prising 75 or 25% non-immune serum by volume, was incubated
at 37◦C for 3 h. For time-course studies, the bacteria/serum mix-
ture, comprising 75 or 25% non-immune serum by volume, was
incubated at 37◦C for 1, 2, and 3 h. The colony count was deter-
mined by plating of serial dilutions on LB agar, and the mean
survival ratio was plotted. A mean survival ratio ≥1 corresponds
to serum resistance.
MOUSE INOCULATION EXPERIMENTS
Virulence was evaluated by mortality in a murine model of sep-
ticemia generated by intraperitoneal (IP) injection. Groups of
five-week-old female BALB/c mice were infected IP with the
K. pneumoniaeNTUH-K2044 (or the isogenic mutants) in 0.1mL
of 0.95% saline (1 × 102 CFU/mouse; 8 mice for each group).
The exact inoculation dose was confirmed by serial dilution and
plating to LB agar and survival rate of mice was monitored for
4 weeks. For in vivo competition, the wbbY mutant strain and
the fully virulent placZ deletion mutant were grown (separately)
to log-phase in LB broth, mixed at a 1:1 ratio (the initial dose
was 1 × 103 CFU each) in 100μL sterile saline, and inoculated
IP into 5-week-old BALB/c mice (8 for each group). The mice
were sacrificed at 24 h post-inoculation, and the spleen and liver
were removed and homogenized in 1x PBS. The concentrations of
bacteria in each sample were determined as described previously
(Hsieh et al., 2010). The output/input ratio of the test strain to the
virulent strain, the competitive index (CI), was interpreted as the
in vivo survival capacity. For active immunization, five-week-old
BALB/cByl mice were immunized three times by once-weekly IP
injection with the indicated dose of the live magA single mutant
ormagA wbbY double mutant. Age-matched, unimmunized con-
trol mice (10 mice per group) were primed with an equivalent
volume of saline on the same schedule. After 4 weeks, immu-
nized and unimmunized control mice were challenged with the
lethal dose 1 × 103 CFU of NTUH-A4528 (O1:K2). The chal-
lenged mice were observed for 28 days for mortality and clinical
signs. Survival was analyzed by Kaplan-Meier analysis with a
log-rank test; a P value <0.05 was considered to be statistically
significant. For passive protection, 100μL of serum derived from
immunized and unimmunized control mice were administered to
five-week-old BALB/cByl mice by IP injection. One hour after
serum injection, mice were infected IP with 1 × 103 CFU of
NTUH-A4528 (O1:K2) or 1 × 106 CFU of E. coli F8188-41 per
mouse. Three hour after infection, the mice were euthanized and
bacterial counts from liver and spleen were determined.
STATISTICAL ANALYSES
Data are presented as means ± standard deviations (SDs).
Statistical significance was assessed by a two-tailed Student’s t
test using Prism 5 (Graphpad) software. Prevalence was analyzed
by chi-square test using SPSS version 12.0 software. Survival was
analyzed by Kaplan-Meier analysis with a log-rank test. P values
of <0.05 were considered significant.
RESULTS
ISOLATION OF K. pneumoniae BACTERIOPHAGE O1-1
The magA deletion mutant, which was derived from the NTUH-
K2044 (K1:O1), lacks the outermost capsule, thereby exposing the
O1 antigen (Hsieh et al., 2012). In the present study, we isolated
a K. pneumoniae O1-1-specific bacteriophage using the magA
mutant. A magA mutant lawn was successfully lysed by bacterio-
phage O1-1, yielding visible plaques from phage titers as low as
10 PFU (Figure 1A). In contrast, the wild-type, the wbbOmutant
(LPS mutant), and the magA wbbO double-mutant (CPS- and
LPS-lacking) strains were all resistant to lysis by bacteriophage
O1-1, even when the viral titer was elevated to 105 PFU. This
result demonstrates that bacteriophage O1-1 did not infect the
encapsulated K. pneumoniae bacteria, presumably due to masking
of the receptor by CPS.
SCREENING AND IDENTIFICATION OF BACTERIOPHAGE
O1-1-RESISTANT MUTANTS
We constructed a magA deletion strain transposon library con-
taining 2500 mutants to screen for genes associated with LPS
biosynthesis. Phage O1-1-resistant mutants derived from the
magA mutant were classified into two types, distinguished by
their sensitivity to the O1-1 phage on spot tests. Among 17
phage O1-1-resistant mutants, 16 isolates (94%) were fully resis-
tant to lysis by phage O1-1, even when the viral titer was ele-
vated to 105 PFU. In Figure 1A, this class is represented by the
16-1C mutant. In contrast, 1 of the 17 phage O1-1-resistant
mutants, designated 17-9F, showed visible plaques when the
viral titer was raised to 102 PFU (Figure 1A). The transposon-
insertion sites of these 17 phage O1-1-resistant mutants were
determined by semi-random PCR and DNA sequencing. The
resulting sequences were analyzed by comparison to the genome
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FIGURE 1 | The K. pneumoniae O1 mutants. (A) The K. pneumoniae
NTUH-K2044 wild-type, magA deletion, wbbO deletion, magA wbbO
double-deletion mutants and magA deletion transposon mutant strains,
16-1C and 17-9F, were grown to mid-log phase at 37◦C and spread on LB
plates. Serial dilutions of SM buffer containing phage O1-1 were dotted onto
the bacterial lawn and grown at 37◦C for 16–18 h. PFU, plaque forming unit.
(B) Transposon insertion sites within the wb cluster in the NTUH-K2044
magA mutants. Arrows denote the orientations of the ORFs. (C) The
composition of K. pneumoniae O1 LPS and the gene responsible for each
step. (D) Genetic organization of wbbY, wbbZ (or their homologs), and their
flanking regions in K. pneumoniae NTUH-K2044 (upper) and E. coli SMS-3-5
(lower). Arrows denote the orientations of the ORFs.
sequence of strain NTUH-K2044 (accession number AP006725).
The analyses showed that 15 mutants harbored insertions within
the wb cluster: five in wbbM, four in wbbN, two in wbbO, two in
wzt, one in wzm, and one in glf (Table 1, and Figure 1B). Mutant
16-1C had an insertion in wecA, which initiates LPS biosynthesis
by catalyzing the transfer of GlcNAc-1-phosphate onto unde-
caprenyl phosphate, generating undecaprenyl-pyrophosphoryl-
GlcNAc (Figure 1C) (Lehrer et al., 2007). Mutant 17-9F was
disrupted in a hypothetical protein-encoding gene; consistent
with The Bacterial Polysaccharide Gene Nomenclature scheme
(BPGN) (Reeves et al., 1996), this ORF is designated as wbbZ
(Figure 1D).
GENETIC ANALYSIS OFwbbY ANDwbbZ
Analysis using the BlastX program showed that the predicted
WbbZ protein shares a conserved domain with CsaB of Bacillus
subtilis, which is a pyruvyl transferase required for polysac-
charide biosynthesis (Mesnage et al., 2000). The gene adja-
cent to wbbZ, wbbY, encodes a putative glycosyltransferase that
might be involved in the synthesis of oligosaccharides, polysac-
charides, and glycoconjugates by transferring the sugar moiety
from a sugar donor onto an acceptor (Figure 1D). The nearby
flanking genes, kp0660, kp0661, and kp0664, are all putative
transposase-encoding genes that are likely not associated with
the biosynthesis of LPS. Moreover, WbbY and WbbZ share
99% amino acid sequence identity with EcSMS35_2255 and
EcSMS35_2256 of E. coli SMS-3-5; these E. coli gene products
have been conjectured to contribute to LPS biosynthesis, though
the proteins were not further characterized (Fricke et al., 2008).
This genetic evidence encouraged us to investigate the associ-
ation between the wbbY-wbbZ region and LPS biosynthesis of
K. pneumoniae.
GLYCOSYLTRANSFERASE WbbY IS ESSENTIAL FOR THE PRODUCTION
OF D-GaL II
The sequence features of the wbbY-wbbZ region suggested that
wbbY and wbbZ are transcribed as a divergent gene pair; how-
ever, these two genes are only separated by a very short intergenic
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Table 1 | LPS mutants in the K. pneumoniae magA transposon mutant library.
Mutant Probable
interrupted
gene
Function/probable function Locus tag
(NTUH-K2044
ORF)
Gene size (bp) Tn insertion
point
3-4A wbbM Putative glycosyltransferase KP1_3696 1908 1207
4-5B wbbO Bifunctional galactosyltransferase KP1_3693 1143 70
7-6D wbbM putative glycosyltransferase KP1_3696 1908 1647
9-3E wbbN Putative glycosyltransferase KP1_3694 894 293
9-10D wbbM Putative glycosyltransferase KP1_3696 1908 1635
10-12F wbbN Putative glycosyltransferase KP1_3694 894 517
11-7F wbbM Putative glycosyltransferase KP1_3696 1908 313
16-1C wecA UDP-GlcNAc:undecaprenylphosphate
GlcNAc-1-phosphate transferase
KP1_0146 1104 903
17-9F wbbZ Hypothetical protein KP1_0663 810 663
21-5A wbbN Putative glycosyltransferase KP1_3694 894 109
22-9F wzm Lipopolysaccharide O-antigen ABC
transport system transmembrane
component
KP1_3698 780 368
22-12A wzt Lipopolysaccharide O-antigen ABC
transport system ATP-binding
component
KP1_3697 741 689
24-2A wbbO Bifunctional galactosyltransferase KP1_3693 1143 287
24-3B wzt Lipopolysaccharide O-antigen ABC
transport system ATP-binding
component
KP1_3697 741 149
25-3F wbbN Putative glycosyltransferase KP1_3694 894 280
25-8H wbbM Putative glycosyltransferase KP1_3696 1908 1056
26-8B glf Putative UDP-galactopyranose mutase KP1_3695 1155 954
The target gene or bacterial strains studied in this study are mentioned in bold.
region consisting of 97 base-pairs between the postulated ATGs of
these two ORFs. To avoid the polar effects resulting from the sin-
gle mutations, that is, that deletion of wbbY affected the function
of wbbZ and vice versa. Therefore, we determined the transcrip-
tion initiation sites of both the wbbY and wbbZ genes by 5′-RACE
(5′-Rapid Amplification of cDNA Ends) method. The transcrip-
tion start site and promoter region of wbbZ were located within
the short intergenic region between the wbbY and wbbZ genes.
In contrast, the transcription start site and promoter region of
the wbbY gene were located in the coding sequences of wbbZ
(Figure 2A).
To confirm our phage screening results, we constructed in-
frame deletion mutant of wbbY, wbbZ, a non-polar deletion
mutant of wbbZ that retained the upstream end of the wbbZ
ORF (encoding 28 N-terminal amino acids of WbbZ, and cor-
responding to the DNA sequences of the presumed minimal
wbbY promoter) and examined the production of CPS and
LPS in these three mutants (Figure 2B). Growth rate and CPS
production by in-frame deletion of wbbY, wbbZ or the non-
polar wbbZ mutant strain was similar to that of the wild-type
strain (Figures 2C,D). In the case of LPS expression, the wild-
type and the magA mutant strains displayed similar patterns
in both silver staining and immunoblotting, producing both
HMW-LPS and LMW-LPS (Figure 3A). In contrast, the wbbO
mutant strain completely lost its ability to produce O-antigen,
displaying only the core and lipid-A in silver staining. The wbbY
mutant was completely depleted in HMW-LPS. The in-frame
wbbZ deletion mutant was impaired in the production of HMW-
LPS, such that HMW-LPS was detected only at low levels.
Unexpectedly, the non-polar wbbZ mutant expressed HMW-
LPS and the molecule was detected by anti-D-Gal II antiserum
(Figure 3B).
To compensate for the deficiency in D-Gal II synthesis, we
transformed the wbbY and wbbZ single-mutant strains with
plasmids containing either (i) wbbY, (ii) wbbZ with the inter-
genic region between these two genes, or (iii) the wbbY-wbbZ
region, and then examined HMW-LPS production in the trans-
formants. Compared to the vector control, the LPS of wbbY
mutant harboring the wbbY-expressing plasmid shifted to a
region of higher molecular weight, and this molecule was
detected by anti-D-Gal II antiserum (Figure 3A). An even higher
molecular weight LPS was obtained by introducing the wbbY-
wbbZ-expressing plasmid into the wbbY mutant; the size of
the LPS produced by this strain resembled that of the wild-
type strain. Additionally, introduction of the wbbY-expressing
plasmid resulted in a shift to a higher molecular weight of
LPS in the wbbZ mutant. The wbbZ-expressing plasmid did
not compensate for the lack of production of HMW-LPS in
the wbbZ mutant. As expected, the wbbY-wbbZ-expressing plas-
mid fully restored the production of LPS in the wbbZ mutant.
These results indicated that the deletion of the wbbZ gene have
additional polar effects on wbbY, presumably by removing the
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FIGURE 2 | Genetic construction, growth, and CPS production of
K. pneumoniae NTUH-K2044 and its isogenic mutants. (A)
Mapping of transcription start sites of the wbbY and wbbZ genes.
The promoter regions and the proposed −10 and −35 regions are
indicated by gray shading. The transcription start sites are shown by
+1 with arrowheads and in larger font. Deduced amino acid
sequences (in single-letter code) are indicated beginning with an ATG
start codon. (B) Schematic diagram representing the construction of
deletion mutations in the NTUH-K2044 background. The locations and
orientations of the ORFs described in this study are indicated by
arrows. The dashed lines refer to joining of the regions flanking the
deleted target. (C) Mutation of wbbY or wbbZ does not impair
bacterial growth. Overnight cultures of the K. pneumoniae
NTUH-K2044 wild-type strain, wbbY, wbbZ, and wbbZ-NP (non-polar)
mutant strains were individually inoculated into fresh LB medium and
grown at 37◦C. The growth of bacteria was monitored periodically
every hour by plating of serial dilutions on LB agar and counting
CFU. The data represent the means of three independent trials; the
error bars represent the standard deviations. (D) The amount of K1
CPS production of the K. pneumoniae NTUH-K2044 wild-type, and of
the wbbY, wbbZ, wbbZ-NP, and magA single-mutant strains, was
determined by assaying uronic acid content. The data represent the
means of three independent trials; the error bars represent the
standard deviations. ∗∗P < 0.01 by Student’s t-test (compared to the
wild-type strain); other comparisons were not statistically significant
(P ≥ 0.05).
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FIGURE 3 | The LPS profiles of K. pneumoniae NTUH-K2044 and its
isogenic mutants. (A) EPS specimens were prepared from K. pneumoniae
NTUH-K2044, from wbbY and wbbZ single mutants, and from the same
mutants harboring complementation plasmids. Extracts from normalized
bacterial suspensions (108 CFU) were separated by SDS-PAGE and visualized
by silver staining (upper) or immunoblotting with anti-D-Gal II antiserum
(lower). HMW-LPS, high-molecular-weight LPS. LMW-LPS, low-molecular-
weight LPS. (B) EPS specimens were prepared from K. pneumoniae
NTUH-K2044, from wbbZ and wbbZ-NP single mutants, and from mutants
harboring complementation plasmids. Extracts from normalized bacterial
suspensions (108 CFU) were separated by SDS-PAGE and visualized by silver
staining (upper) or immunoblotting with anti-D-Gal II antiserum (lower). (C,D)
EPS extracted from Klebsiella K72:O2, E. coli DH5α, and K. pneumoniae
wbbY mutant strains harboring the indicated plasmids were separated by
SDS-PAGE and the LPS patterns were visualized by silver staining (upper) or
immunoblotting with anti-D-Gal II antiserum (lower). (E) The 1H-NMR spectra
of the LPS of the wbbY mutant. LPS specimens were prepared from the
Klebsiella K72:O2 capsule-deficient mutant (K72wza wzb), the
K. pneumoniae NTUH-K2044 magA deletion strain, the magA wbbY
double-deletion mutants, and the magA wbbY double-deletion strain
containing the wbbY -expressing plasmid. The four D-galactosyl residues are
indicated (a to d) according to decreasing anomeric 1H shifts.
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promoter ofwbbY. Thus, these results implied that onlywbbY was
essential for the production of D-Gal II in the K. pneumoniae O1
strain.
wbbY ANDwbbZ ARE SUFFICIENT FOR THE BIOSYNTHESIS OF
D-GaL II
To investigate whether the wbbY-wbbZ region was sufficient for
the expression of D-Gal II, we individually introduced plas-
mids containing (i) wbbY, (ii) wbbZ with the intergenic region
between these two genes, (iii) wbbY with its intact promoter
sequence, or (iv) the entire wbbY-wbbZ region into the Klebsiella
K72 reference and the wbbY single-mutant strains. The Klebsiella
K72 reference strain is an isolate that produces O2 antigen,
which is composed only of D-Gal I and runs as LMW-LPS
and is not recognized by anti-D-Gal II antiserum (Figure 3C).
Introduction of a plasmid carrying wbbY with its intact pro-
moter sequence enabled the K72 and the wbbY single-mutant
strains to produce partial D-Gal II antigen of increased molec-
ular weight that was weakly detected by anti-D-Gal II antiserum
(Figure 3D). Interestingly, the introduction of the entire wbbY-
wbbZ region into the K72 strain enabled the bacterium to produce
D-Gal II. This results parallels the full restoration of D-Gal II
antigen production to the wbbY mutant strain upon comple-
mentation with the plasmid containing the entire wbbY-wbbZ
region.
Additionally, we compared the 1H-NMR spectra of LPS
obtained from the wbbY-deletion mutant, from the wbbY mutant
harboring thewbbY-expressing plasmid, and from the K72 strain.
To rule out the possibility of CPS contamination during LPS
analysis, we constructed these mutants in the K-antigen-deficient
background. Consistent with the previous NMR assignment
(Whitfield et al., 1991), we found that the LPS of the magA wbbY
double-deletion mutant strain contained primarily D-Gal I [H-
1a: -3)-β-D-Galf-(1- at 5.18 ppm) and H-1c: -3)-α-D-Galp-(1-
at 5.06 ppm], resembling the LPS derived from the K72 wza wzb
double-deletion mutant strain (D-Gal I). In contrast, the LPS of
the magA wbbY double-deletion mutant harboring the wbbY-
expressing plasmid and that of themagAmutant strain contained
both D-Gal II [H-1b: -3]-α-D-Galp-(1- at 5.15 ppm and H-1d:
-3)-β-D-Galp-(1- at 4.66 ppm] and D-Gal I (Figure 3E). In addi-
tion, we tried to express the K. pneumoniae O1 antigen in E. coli.
Co-transformation of E. coliDH5α with two plasmids containing
the wb cluster and the entire wbbY-wbbZ region enabled the bac-
terium to express a typical smooth lipopolysaccharide that could
be detected by anti-D-Gal II antiserum, though the molecular
weight was slightly lower than that produced in K. pneumoniae
(Figure 3C). No HMW-LPS or smooth LPS was detected in those
bacteria containing plasmids carrying the wb cluster only or with
vector alone. Taken together, these genetic and chemical anal-
yses indicate that both wbbY and wbbZ were sufficient for the
expression of D-Gal II.
PREVALENCE OF THE D-GaL II ANTIGEN IN K. pneumoniae CLINICAL
ISOLATES
In order to detect the production of D-Gal II, we generated and
evaluated antiserum raised against LPS D-Gal II by immuniza-
tion of a rabbit with the unencapsulated magA mutant (K−1 O1).
Antiserum raised against the magA mutant reacted with all (20
of 20) of randomly selected Klebsiella reference strains, which
are known to belong to the O1 serotype and produce D-Gal
II. In contrast, this antiserum did not react with the Klebsiella
K72 strain, an isolate that is known to belong to the O2 type
and produce D-Gal I only (Figure 3C). Therefore, the antiserum
isolated from the magA-mutant-immunized rabbit is specific to
D-Gal II. Using this tool, we compared the distribution of D-
Gal II by immunoblotting of samples from 74 clinical isolates
of K. pneumoniae, including 42 PLA strains and 32 non-tissue-
invasive strains. The D-Gal II-containing strains accounted for
63.5% of all clinical isolates, with significant differences in repre-
sentation among the strains that caused PLA (38/42; 90.5%) and
those that were not tissue-invasive (9/32; 28.1%) (P < 0.0001,
chi-squared test).
OCCURRENCE OF WbbY ANDWbbZ HOMOLOGS IN THE E. coli O19
STRAIN AND OTHER GRAM-NEGATIVE BACTERIA
A previous study indicated that the E. coli O19 antigen is recog-
nized by an anti-Klebsiella O1 monoclonal antibody (McCallum
et al., 1989; Fricke et al., 2008). We therefore investigated the
link between the wbbY and wbbZ genes and structures based on
D-Gal II synthesis in the E. coli O19-type bacterium. Specifically,
we carried out PCR analysis using primer pairs located within
the wbbY and wbbZ genes. Positive signals were obtained from
the acapsulated E. coli O19ab K−:H7 strain, F8188-41; the ampli-
cons were of the same sizes as those obtained from K. pneu-
moniae NTUH-K2044 and A5054, which are known O1-type
strains (Figure 4A). We then carried out immunoblotting anal-
ysis using the anti-D-Gal II antiserum. All wbbY-, wbbZ-positive
strains, including F8188-41, showed positive signals. In addition,
D-Gal II was immunologically detected in all of the wbbY and
wbbZ single-mutant and the K72 harboring the F8188-41 wbbY-
wbbZ-expressing plasmid strains (Figures 4B,C). These results
suggested that D-Gal II is present in the LPS of the E. coli O19
group. Moreover, we also determined the DNA sequences of the
wbbY and wbbZ genes from F8188-41, which were clustered on
the chromosome and showed 95% DNA sequence identity com-
pared with those from the NTUH-K2044 and another O19-type
E. coli strain, SMS-3-5. The WbbY and WbbZ homologs from
K. pneumoniae NTUH-K2044 and E. coli SMS-3-5 showed 99%
protein sequence identity and belong to the same branch by phy-
logenetic tree analysis (Figure 4D); the E. coli F8188-41 homologs
showed lower protein sequence similarity and sorted as a sepa-
rate phylogenetic branch. To investigate the presence of WbbY
and WbbZ homologs in other bacteria, we searched the NCBI
database of encoded sequences from other bacterial genomes by
BLASTp. WbbY and WbbZ homologs were detected in another
member of the Klebsiella genus (K. oxytoca) and in four other
more distantly related Gram-negative bacteria (E. coli, Erwinia
piriflorinigrans, Serratia plymuthica, and Commensalibacter intes-
tine). In each of these species, the wbbY and wbbZ gene were
adjacently located on the respective chromosome and also as
divergent transcription units (Table 2). These observations sug-
gested that the D-Gal II structure described in the present
study also may be present in Gram-negative bacteria of multiple
genera.
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FIGURE 4 | Analysis of WbbY and WbbZ homologs in K. pneumoniae
and other Gram-negative bacteria. (A) PCR detection of wbbY (830 bp)
and wbbZ (583 bp)—like genes. lane M, 1 kb DNA ladder; NC, no-template
control. (B) EPS specimens were prepared from K. pneumoniae NTUH-
K2044; isogenic mutants of K2044; strain A5054; the Klebsiella K72 wild
type; K72 wza wzb double mutant; and E. coli O19 ab K−:H7 F8188-41.
Extracts from normalized bacterial suspensions (108 CFU) were separated by
SDS-PAGE and visualized by immunoblotting with anti-D-Gal II antiserum. (C)
EPS extracted from the wbbY and wbbZ single-mutant and Klebsiella
K72:O2 strains harboring the indicated plasmid was separated by SDS-PAGE
and the LPS patterns were analyzed by immunoblotting with anti-D-Gal II
antiserum. (D) Phylogenetic analysis of WbbY and WbbZ homologs from
different Gram-negative bacteria using the SMART (Simple Modular
Architecture Research Tool) database.
D-GaL II IS REQUIRED FOR K. pneumoniae’s SERUM RESISTANCE AND
VIRULENCE IN VIVO
Serum killing assays were performed on the K. pneumoniae wbbY
and non-polar wbbZ single-deletion mutants to determine the
mutants’ sensitivities to serum bactericidality. Exposure to human
serum (75% human serum for 3 h) resulted in higher levels of
killing in the wbbY mutant than in the wild-type and non-polar
wbbZ mutant strains (Figure 5A); the wild-type and non-polar
wbbZ mutant strains exhibited similar levels of resistance to
serum killing. Moreover, introduction of plasmid carrying either
wbbY alone or the entire wbbY-wbbZ region successfully restored
serum resistance levels to the wbbY mutant strain. This result
confirmed that resistance to serum killing correlated with the
production of D-Gal II.
To delineate the contribution of CPS, D-Gal I, and D-Gal
II to K. pneumoniae’s serum resistance, the survival ratio of
the wild-type, magA, wbbO, wbbY and non-polar wbbZ single-
deletion mutant strains after killing by 75 and 25% human
serum was assessed at one-hour intervals through 3 h of expo-
sure (Figures 5B,C). Mutation of magA dramatically reduced the
serum resistance of the NTUH-K2044, presumably because the
mutant lacked K1 antigen. As expected, wbbO mutation resulted
in the loss of O1 antigen; the mutant exhibited elevated sus-
ceptibility to serum killing compared to the wild-type, wbbY,
and non-polar wbbZ mutant strains. The wbbY mutant, which
lacked D-Gal II, showed more susceptible to serum killing than
the wild-type and non-polar wbbZ mutant strains. These results
demonstrated that the sensitivity to serum killing of the K1:O1
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Table 2 | Co-existence of WbbY and WbbZ homologs in bacterial genomes.
Strain Homolog of *
WbbY WbbZ
Locus tag Length (aa) Identity (%) Locus tag Length (aa) Identity (%)
K. pneumoniae†
NTUH-K2044 WbbY 740 100 WbbZ 269 100
BWH 28 L399_04783 740 100 L399_04784 269 100
BWH 30 L401_04931 740 100 L401_04932 269 100
K. oxytoca
10-5242 HMPREF9686_04614 740 93 HMPREF9686_04613 269 89
10-5250 HMPREF9694_03631 740 93 HMPREF9694_03630 269 90
M5al KOXM_19447 648 93 KOXM_19452 269 90
E. coli
SMS-3-5 EcSMS35_2255 740 99 EcSMS35_2256 269 99
113290 HMPREF1589_00988 740 99 HMPREF1589_00989 269 99
F8188-41 WbbY 740 96 WbbZ 269 94
KTE108 A1WU_05025 740 96 A1WU_05024 269 94
909945-2 HMPREF1620_00779 663 96 HMPREF1620_00778 269 94
E. piriflorinigrans
CFBP 5888 EPIR_1323 758 67 EPIR_1324 270 66
S. plymuthica
A30 B194_1630 736 63 B194_1629 270 63
C. intestine
A911 CIN_12230 886 53 CIN_12220 266 55
*E value < 10−10.
†100% identity of WbbY and WbbZ homologs in the NTUH-K2044 and other K. pneumoniae starins were shown. The target gene or bacterial strains studied in this
study are mentioned in bold.
K. pneumoniae strain depended on the integrity of bacterial
surface polysaccharides.
To evaluate the contribution of the LPS D-Gal II ofK. pneumo-
niae in bacteremia, we challenged mice with the same dose (1 ×
102 CFU) of the wild-type and wbbY deletion-mutant strains.
Upon IP infection of mice, the wbbY mutant showed significantly
reduced virulence compared to the parent strain (P = 0.024,
Figure 5D). Previously, we generated an isogenic lacZ mutant
with its promoter deletion and used it as the wild-type strain in
the competition assay (Hsieh et al., 2010). In those experiments,
no competitive advantage was observed for either the wild type or
placZ mutant in the spleen and liver of BALB/c mice. Using the
same assay in the present study, the wbbY mutant strain showed
lower competitive indices than the wild type or placZ mutant
(P < 0.001, Figure 5E). These results indicated that D-Gal II was
required for K. pneumoniae’s serum resistance and contributed to
in vivo virulence.
PROTECTIVE EFFECT OF ANTI-D-GaL II ANTIBODIES DURING
K. pneumoniae INFECTION
To evaluate the protective efficacy of immunization against D-
Gal II, mice were pretreated by IP injection with either magA or
magA wbbY (1 × 106 CFU per dose), administered once weekly
for 3 weeks. On the fourth week, the animals (in groups of 10)
were challenged IP with a lethal dose of highly virulent K. pneu-
moniae NTUH-A4528 (O1:K2). Within 6 days of NTUH-A4528
infection, 100% of the unimmunized control mice or the mice
pre-immunized with the magA wbbY double-mutant strain died.
Meanwhile, 70% of the mice pre-immunized with the magA-
mutant (K−1 O1) survived without any symptoms of disease
through 28 days after challenge (P < 0.0001, Figure 5F). Mice
immunized with the magA mutant (K−1 O1) showed anti-D-Gal
II immunoglobulin G (IgG) production by immunoblot; mice
immunized with themagAwbbY doublemutant or unimmunized
control mice did not (Figure 5G).
The results of the immunization study were consistent with a
separate test in which the passive protective efficacy of anti-D-Gal
II antiserum was tested. In the passive immunization study, mice
were pretreated with immune mouse sera (negative and positive
controls, respectively). The in vivo protective capacity of the sera
was tested using aK. pneumoniae or an E. coli septicemia infection
model, whereby the mice were inoculated IP with 1 × 103 CFU
of the encapsulated K. pneumoniae NTUH-A4528 (O1:K2) or
1 × 106 CFU of the acapsulated E. coli F8188-41 (O19) strain. The
bacterial load was determined in both the liver and spleen at 3 h
post-infection. Compared to animals pre-treated with the magA
wbbY double-mutant immune mouse serum (IMS-NC), mice
pretreated with the magA mutant immune mouse serum (IMS-
PC) had significantly reduced bacterial loads (Figure 5H). These
results indicated that in both active and passive immunization
studies, D-Gal II-specific antiserum was able to reduce bacte-
rial dissemination and protect against infection by encapsulated
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FIGURE 5 | Serum sensitivity and virulence of NTUH-K2044 and its
isogenic mutants. (A–C) Serum sensitivity assays of resistance to killing by
non-immune healthy human serum of the NTUH-K2044 wild-type; wbbY,
wbbZ, wbbZ -NP, magA, and wbbO single-deletion mutants; and the
respective complemented strains. The data represent the means of three
independent trials; the error bars represent the standard deviations. A mean
survival ratio ≥1 corresponds to serum resistance. ∗∗P < 0.01 or ∗P < 0.05
by Student’s t test (compared to the wild-type strain). (D) Eight mice per
group were infected with the NTUH-K2044 wild-type and the wbbY mutant
strains at an intraperitoneal (IP) dose of 1 × 102 CFU/animal. Survival of mice
was monitored for 4 weeks. , NTUH-K2044; , wbbY mutant (wbbY vs.
parent, P = 0.024; log-rank test). (E) Survival of the isogenic K. pneumoniae
wbbY (open triangles) mutant in the in vivo bacterial competition model,
using competition against the fully virulent placZ mutant in groups of eight
mice. The ratio of lacZ+ or lacZ− K. pneumoniae (close squares) colonies in
the contents of the spleen and liver was determined from a single mouse at
sacrifice (24 h post-infection). Each symbol represents the competitive index
(CI) for each inoculum; and the medians and SDs of the values are shown (for
the wild-type strain group vs. placZ mutant group, the CI of spleen and liver
were 1.016 ± 0.206 and 1.009 ± 0.286, respectively; wbbY mutant group vs.
placZ mutant group, the CI of spleen and liver were 0.553 ± 0.089 and 0.564
± 0.123, respectively; P = 0.001, Wilcoxon’s signed rank test). (F) Survival of
mice immunized with magA mutant and then challenged with NTUH-A4528
(O1:K2). Mice (10 per group) were inoculated three times by once-weekly IP
injections with 1 × 106 CFU of magA mutant or magA wbbY double-mutant
strain. Age-matched, unimmunized control mice were inoculated with saline.
On the fourth week, immunized or unimmunized groups were challenged
with NTUH-A4528 (1 × 103 CFU per animal, IP). Survival was assessed for 28
days following infection. , non-immunized, NTUH-A4528 challenged; ,
magA mutant immunized, NTUH-A4528 challenged; ♦, magA wbbY double
mutant immunized, NTUH-A4528 challenged. By log-rank test: P < 0.0001,
magA/NTUH-A4528 vs. non-immune/NTUH-A4528 or magA
wbbY /NTUH-A4528. (G) Immune response of anti-D-Gal II IgG in magA
mutant-immunized mice. Immunoblots developed with magA mutant
immune mouse serum (1:500) or magA wbbY double-mutant immune
mouse serum (1:500). (H) Anti-D-Gal II specific antibodies reduce growth of
NTUH-A4528 (O1:K2) K. pneumoniae and E. coli F8188-41 (O19) in mice.
Groups of 4 BALB/c mice were treated with magA mutant immune mouse
serum (IMS–positive control, IMS-PC) or with magA wbbY double-mutant
immune mouse serum (IMS–negative control, IMS-NC). One hour after
injection, mice were infected with 1 × 103 CFU of the NTUH-A4528
(KP-IMS-PC and KP-IMS-NC) or 1 × 106 CFU of E. coli F8188-41 (EC-IMS-PC
and EC-IMS-NC) by IP injection. Three hours after infection, the numbers of
bacteria in the liver and spleen were determined. Log10 CFU was
standardized per 0.1 gram wet organ weight. The black and white bars
represent the means for each group for liver and spleen, respectively. Data
are presented as means ± SD. ∗∗P < 0.01 or ∗P < 0.05 by Student’s t test
(KP-IMS-PC vs. KP-IMS-NC and EC-IMS-PC vs. EC-IMS-NC).
O1:K2 PLA-associatedK. pneumoniae and by D-Gal II-containing
E. coli in mouse models of septicemia.
DISCUSSION
In this study, we identified 17 K. pneumoniae magA-deletion
transposon mutants resistant to the bacteriophage O1-1. Among
these mutants, 16 mutants were disrupted in well-characterized
LPS-biosynthesis genes: 15 were in the wb-cluster genes, and 1
was in wecA, indicating that a bacteriophage screening method
was very useful. The last mutant represented a transposon inser-
tion into wbbZ (formerly designated kp0663), a locus located well
away from the wb cluster [located in a region formerly designated
kp3698 (wzm) to kp3693 (wbbO)]. This result was consistent with
the previous finding that genes involved in the expression of
D-Gal II were not closely linked to the wb cluster (Whitfield et al.,
1991).
The gene adjacent to wbbZ, wbbY, has apparent carbohydrate
transferase functions and conserved among D-Gal II synthesiz-
ing organisms. The sequence features of this region suggested that
these two genes are adjacently located on the respective chromo-
some and also as divergent transcription units; however, they are
only separated by a very short intergenic region. Indeed, mapping
of the transcription initiation sites of the two genes of the NTUH-
K2044 revealed that the transcription start site of the wbbY gene
was located within the coding region of wbbZ, apparent over-
lap of regulatory sequences so that wbbZ insertion has polar
effects on wbbY. More detailed studies will be needed to clarify
the regulation and interaction of these overlapping promoters.
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Silver staining revealed that the wbbY mutant had enriched
LMW-LPS, but lacked HMW-LPS. Trans-complementation of the
wbbY mutation by the wbbY-expressing plasmid resulted in the
production of LPS with a molecular weight between those of the
LPS of the wild-type andmutant strains; this intermediate molec-
ular weight product was detected by anti-D-Gal II antiserum.
These findings suggest that wbbY encodes a glycosyltransferase
that has a central role in the elongation of D-Gal II. The D-
Gal II structure is the difference between the LPS composition
of K. pneumoniae serotypes O1 and O2. Expression of the entire
wbbY-wbbZ region in a Klebsiella O2 strain enabled the bac-
terium to express HMW-LPS that was recognized by anti-D-Gal
II antiserum. Furthermore, co-transformation of E. coli DH5α
with two plasmids carrying the K. pneumoniae wb cluster and the
wbbY-wbbZ regions permitted the E. coli K-12 recipient (which
normally produces rough LPS consisting of only lipid A-core)
to produce a typical smooth LPS ladder. These pieces of evi-
dence support the contention that both thewbbY andwbbZ genes
are sufficient for the biosynthesis of D-Gal II. Determination of
their precise functions in D-Gal II assembly awaits further study.
The current data suggests that WbbZ participates in some other
way, perhaps involving termination of the elongation process,
following the step catalyzed by WbbY.
Sequence analysis also showed that WbbY and WbbZ shared a
high degree of sequence similarity with two putative LPS biosyn-
thesis genes of SMS-3-5, an E. coli O19:H34 strain (McCallum
et al., 1989; Fricke et al., 2008). Interestingly, an early study
indicated that the E. coli O19 antigen could be recognized by a
Klebsiella O1 antigen-specific monoclonal antibody (McCallum
et al., 1989; Fricke et al., 2008). This connection led us to the rea-
sonable assumption that the E. coli O19 group has an O-antigen
structure similar to that of Klebsiella O1, as well as the genetic
apparatus required for synthesis of O antigen. That is exactly what
we demonstrate in this study: a genetic apparatus for D-Gal II
biosynthesis is present in the E. coli O19 group. Therefore, it is
conceivable that WbbY and WbbZ participate in the assembly of
D-Gal II-containing LPS in the K. pneumoniae serotype O1 and
the E. coli serotype O19 strains.
Previous studies reported that D-Gal I and structures based
on D-Gal I are found in a variety of Klebsiella O serotypes, as
well as in Serratia plymuthica, S. marcescens O16 and O20, and
Pasteurella hemolytica serotypes 4 and T10 (Oxley andWilkinson,
1989; Richards and Leitch, 1989; Whitfield et al., 1992; Aucken
et al., 1993; Kelly et al., 1993). However, D-Gal II is only found
in O-antigen from Klebsiella serotypes O1 and O8, and in S. ply-
muthica (Aucken et al., 1993; Kelly et al., 1993). In fact, database
searches performed as part of the present study indicate WbbY
and WbbZ homologs are present in several bacterial genera,
especially within the Enterobacteriaceae. Taken together, it is con-
ceivable that WbbY and WbbZ homologs participate in the
assembly of D-Gal II-containing LPS in a wider and previously
unappreciated range of Gram-negative bacteria.
Deletion of thewbbY gene impaired the survival of the NTUH-
K2044 in human serum, presumably because the mutant lacked
D-Gal II. This result is consistent with an earlier finding that the
presence of D-Gal II is required for the resistance of K. pneumo-
niae to serum killing (McCallum et al., 1989). The importance
of the bacterial surface EPS to serum resistance of the O1:K1
K. pneumoniae strain is ranked in decreasing order from K1 anti-
gen, O1 antigen, D-Gal I, and D-Gal II. Upon in vivo infection,
the D-Gal II-deficient K. pneumoniae mutant is less virulent than
the parental strain. Loss of D-Gal II production in K. pneumo-
niae restricts the spread of the bacteria to distant organs, reducing
mice mortality. Thus, these findings indicate that mutation of the
K. pneumoniae gene coding for D-Gal II biosynthetic machin-
ery results in changes in serum resistance; reducing bacterial
dissemination and colonization into deep organs.
The O antigen is the most external component of the LPS. In
the present study, D-Gal II-specific antiserum was obtained from
a rabbit immunized with a magA mutant (K−1 O1) strain. This
result indicates that D-Gal II is the immunodominant antigen
of the LPS O1 antigen of K. pneumoniae. The high prevalence
(90.5%) of D-Gal II in PLA strains indicates that the D-Gal
II-producing strains are predominant among K. pneumoniae iso-
lates causing PLA. Earlier results showed that K antigen and
LPS are exposed together at the cell surface in K. pneumoniae
O1 strains harboring CPS serotype K2 (Merino et al., 1992).
Clements et al. used K. pneumoniae B5055 (O1:K2), a pneumonia
strain, to show that immunization with purified LPS can pro-
tect mice against lethal challenge with either O1:K2 or O2:K1
K. pneumoniae infection (Clements et al., 2008). In the present
study, mice immunized with the magA mutant (K−1 O1) induced
the production of antiserum against D-Gal II, and this antiserum
had a significant protective efficacy against the PLA-associated
O1:K2 strain. In passive immunization studies, D-Gal II-specific
antiserum was able to limit the growth and bacterial dissem-
ination of encapsulated O1:K2 PLA-associated K. pneumoniae
or acapsulated O19-type E. coli in mouse models of septicemia.
Therefore, LPS D-Gal II antigen could be a useful vaccine tar-
get conferring broad cross-protection against D-Gal II-containing
Gram-negative bacterial pathogens.
In summary, bacteriophage is a powerful screening tool for
identification of bacterial surface components. The gene encod-
ing glycosyltransferase WbbY is essential for the production of
D-Gal II in K. pneumoniae. Both WbbY and WbbZ homologs
are sufficient for the biosynthesis of D-Gal II. LPS D-Gal II
is more prevalent in PLA strains than in non-tissue-invasive
strains. Besides the Klebsiella O1 strain, the E. coli O19 group
and several other species of Gram-negative bacteria also harbor
WbbY homologs, WbbZ homologs, and LPS structures based
on D-Gal II. Mutation of the gene coding for biosynthesis of
the D-Gal II antigen in K. pneumoniae changes serum resis-
tance; reduces bacterial dissemination and colonization into deep
organs; and decreases mouse mortality upon infection with K.
pneumoniae. D-Gal II is the immunodominant antigen of LPS
and immunization of mice against D-Gal II provides protection
against infection with an O1:K2 PLA-associated K. pneumoniae
strain.
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